Anti-Emetic Drug Reduces Seizures in Temporal Lobe Epilepsy
Administration of prochlorperazine or CLP-257 (or its prodrug CLP-290), significantly decreased seizure frequency in vivo, providing further evidence that enhancing KCC2 function could stabilise neuronal networks.